Royalty Pharma: Stock With Stability During The Bear Market Volatility

Nov. 12, 2022 3:12 AM ETRoyalty Pharma plc (RPRX)

Summary

  • Royalty Pharma has 40 projects in the late stages of development.
  • The company's high profitability margins help drive earnings growth.
  • Royalty's reasonable valuation and strong expected growth are likely to drive the stock to outperform.
  • Royalty Pharma's stock is likely to hold up better than average due to the nature of the business.
  • Looking for a helping hand in the market? Members of Margin of Safety Investing get exclusive ideas and guidance to navigate any climate. Learn More »

Young female scientist working in laboratory

Solskin

One stock that is likely to hold up better than average during the bear market is Royalty Pharma plc (NASDAQ:RPRX). The company is the largest buyer of biopharmaceutical royalties. Royalty Pharma also is a leading company that

Royalty Pharma stock chart rising RSI MACD crossover

stockcharts.com

Consider joining Kirk Spano's Margin of Safety Investing which offers a more in-depth analysis of individual companies.

Try Margin of Safety Investing free for two weeks and get your first year for 20% off.

Learn the 4-step investment process that top hedge funds use.

Invest with us in a changing world that demands a margin of safety.

This article was written by

David Zanoni profile picture
9.21K Followers
Join MarketWatch Award Winner Kirk Spano For More Profits & Less Risk.

Through diligent analysis, he is ranked in the top 1% of blogging analysts on Tipranks.com for performance and accuracy. David previously contributed to Kirk Spano's Margin of Safety Investing [MoSI] Marketplace Service and Risk Research Inc.

David focuses on growth & momentum stocks that are reasonably priced and likely to outperform the market over the long-term. He is a long term investor of quality stocks and uses options for strategy.

David told investors to buy in March 2009 at the bottom of the financial crisis. The S&P 500 increased 367% and the Nasdaq increased 685% from 2009 through 2019.

He wants to help make people money by investing in high-quality growth stocks.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: The article is for informational purposes only (not a solicitation or recommendation to buy or sell stocks). David is not a registered investment adviser. Investors should do their own research or consult a financial adviser to determine what investments are appropriate for their individual situation. This article expresses my opinions and I cannot guarantee that the information/results will be accurate. Investing in stocks involves risk and could result in losses.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.